Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,936 total articles
Moody's (MCO) is trading below its recent highs after a broad market pullback. With $2.6B in free cash flow, a 60%+ ROE, and recurring Analytics revenue, the business can withstand cyclical issuance slowdowns. Valuation at ~31x earnings and $77B market cap isn't a bargain, but the combination of durable economics and a near-term technical setup sup…
ITA (iShares U.S. Aerospace & Defense ETF) provides concentrated exposure to U.S. defense primes and aerospace suppliers. With renewed geopolitical risk tied to the Iran conflict and credible signals that Europe could be the next escalation front, defense flows can reaccelerate. This trade idea lays out a tactical long in ITA with a clear entry at …
Dycom (DY) offers visible near-term revenue growth tied to a record $9.5B backlog and the recent Power Solutions acquisition. Fundamentals and free cash flow support a mid-term long trade while technicals have pulled back to a constructive entry. Trade plan includes an entry at $341.105, a stop at $320.00 and a target at $390.00 over a mid-term (45…
I closed my Alibaba position at current levels and redeployed capital into JD.com. Alibaba's stock is pricing in a capital-intensive AI pivot with uneven near-term profit outcomes; the shares are under pressure from slowing e-commerce and margin compression even as cloud and chip investments accelerate. The trade here is a mid-term (45 trading days…
Avino Silver & Gold (ASM) looks like a durable mining story: diversified silver/gold/copper exposure, a market cap just above $1.0B, and a history of buybacks. Still, stretched valuation versus recent trading, a weakening technical setup and persistent short interest force a rating downgrade to Neutral. Traders can take a tactical long with tight r…
Palantir's operational story - rapid revenue growth, strong cash flow and expanding enterprise AI partnerships - remains intact. The problem for bulls is valuation: the market is pricing near tech royalty with price-to-sales above 80x and a market cap north of $360B. For traders, that makes a mid-term short attractive if momentum and multiple compr…
Canada Goose is a high-quality luxury outerwear franchise trading at roughly $1.05 billion market cap. The stock has pulled back after a weaker quarter and compressed margins, leaving valuation stretched by a P/E of ~76 but supported by strong brand recognition, DTC exposure, and recent insider/institutional buying. Technicals show a mild oversold …
Alphabet has been hammered in a short-lived selloff, pushing RSI into the high-20s and knocking price below several moving averages. Fundamentals remain intact: $3.45T market cap, strong free cash flow ($73.3B), ROE >31% and healthy balance sheet. This is a tactical, mid-term (45 trading days) long setup aimed at capturing a mean-reversion bounce a…
Life Time Group offers a mix of recurring membership revenue, resort-style facilities, and solid profitability metrics that make it a defensive growth name in a jittery consumer backdrop. At a market cap near $5.8B and an EV/EBITDA around 8.5x, the stock looks reasonably valued versus its growth and return profile. This trade idea lays out an actio…
Hermès (HESAY) has pulled back hard from its 2025 highs and sits in oversold territory after a sharp mid-March rout. The fundamentals of a near-century-old luxury house remain intact - premium pricing power, scarce leather-goods capacity, and attractive long-run market growth - creating a buy-the-dip opportunity for disciplined swing traders. We up…
IonQ has shifted from a research story to a revenue-driven growth company. With 2025 revenue near $130M, guidance of $225-245M for 2026 and clear product differentiation in trapped-ion qubits, the stock merits a long trade for patient, risk-aware investors. Price-to-sales remains elevated, so size the position and use a firm stop. This trade plan t…
Symbotic's robotics platform is showing signs of margin improvement and stronger free cash flow, while a multi-billion backlog and JV activity reduce single-customer concentration risk. Technicals and short interest suggest a favorable risk-reward for a disciplined long position with defined stops.
AMD sits at the center of a resurgent CPU market that is being re-priced by AI infrastructure demand. With visible pricing power, low leverage, solid free cash flow, and partnerships that validate its data center roadmap, AMD looks set to re-rate. This trade idea gives an entry at $216.31, a stop at $195.00 and a target of $260.00 over a long-term …
Micron (MU) has the mix every active investor wants: explosive AI-driven demand for memory, strong recent earnings, plentiful free cash flow and conservative leverage. The stock's pullback creates a tactical long entry with clearly defined risk. This trade idea lays out an entry at $382.09, a $470 target and a $330 stop, with reasoning tied to fund…
Equinox Gold is down roughly 31% from its 52-week peak but the company’s balance sheet and production profile argue for a long-term buy. With $1.015B sold from Brazil, net debt trimmed to about $150M, 2026 guidance of 700k-800k ounces, and the start of a dividend and share buyback program, the equity now offers growth optionality with materially lo…
Nvidia is trading like yesterday's story despite commanding AI infrastructure economics: $4.39T market cap, P/E ~36.5, ~76% ROE and roughly $97B in annual free cash flow. This trade idea is a disciplined long that buys current weakness, with a tight stop and layered targets tied to near-term AI catalysts and Q2 seasonality.
Chewy reported margin improvement and explicit AI-driven cost savings on 03/25/2026, and management now models EBITDA margin expansion to 6.7% alongside ~9% top-line growth for fiscal 2026. At a current market cap of about $11.0B and an enterprise value near $9.06B, the stock looks actionable from a risk-reward perspective. This trade idea lays out…
Brown & Brown is trading near its 52-week low after a string of headlines and an organic revenue pullback. The firm's acquisitive model continues to add revenue, improve adjusted margins (35.9% reported for FY2025), and generate free cash flow ($1.382B annually). At ~$64.29 today, Brown & Brown offers asymmetric upside from deal synergies plus a di…
Gen Digital (GEN) has corrected to its 52-week low after a sharp pullback, but recent fundamentals - 26% revenue growth in Q3 FY26, raised FY26 guidance, and $1.5B+ free cash flow - plus oversold technicals suggest a high-probability swing rebound. This trade idea sizes a tactical long entry at $19.50 with a $18.00 stop and a $24.00 target over a m…
Winnebago (WGO) pulled back sharply after mixed Q2 FY2026 results driven by falling unit volumes. The stock is trading near support, shows oversold technicals and still generates healthy free cash flow and a meaningful dividend. This is an actionable mid-term swing trade: enter at $33.00, stop at $30.00, target $42.00 over ~45 trading days, with cl…
Blue Bird's recent beat-and-raise performance, attractive cash generation and reasonable valuation metrics give the stock a clear risk/reward for a mid-term trade. Pricing actions and a durable backlog should give management visibility into a stronger second half; the proposed plan targets a measured upside while limiting downside with a defined st…
Pattern Group (PTRN) pairs accelerating ecommerce tooling and marketplace execution with improving technical and sentiment indicators. Market cap sits at $2.26B while momentum and short-interest dynamics suggest a cleaner runway for a disciplined long trade from current levels. This idea lays out entry, stop, and target with rationale and risks.
Arrowhead (ARWR) looks positioned for a mid-term trade. Positive Phase 1/2a obesity data and improving technicals support a tactical long from $60.50 with a $72 target and $54 stop, targeting a catalyst-driven re-rating over the next 45 trading days. Valuation is rich versus historic norms, so reward-management and close monitoring of trial cadence…
Karyopharm (KPTI) is a commercial-stage oncology company trading near $5 with a market cap under $100M, elevated short interest (~21% of float) and stretched technicals. For traders who want a defined-risk way to play binary trial volatility, a disciplined long into the Phase 3 readout window offers asymmetric upside if the trial surprises positive…
Credo's big post-earnings leg lower has created a controlled entry for traders who want exposure to one of the leading AI data-center interconnect plays. The business is growing north of 200% YoY, producing strong gross margins and free cash flow, while short interest and heavy volume make a snap-back likely if execution stays intact. I lay out a m…
